Get the Stockscreener App
183.08
1.07%
1.94
After Hours:
183.75
0.67
+0.37%
Overview
News
Price History
Option Chain
Financials
Why ABBV Down?
Discussions
Forecast
Dividend History
Abbvie Inc Stock (ABBV) Latest News
AbbVie (NYSE:ABBV) Stock Price Up 1.6%Should You Buy? - MarketBeat
CreativeOne Wealth LLC Increases Stock Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat
AbbVie Inc. (NYSE:ABBV) Position Reduced by MetLife Investment Management LLC - MarketBeat
Bridgewater Associates LP Reduces Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Facial Injectables Industry May See a Big Move | Medytox, AbbVie, Sanofi - openPR
Biopharmaceuticals Market Forecasted for Major Expansion - openPR
Loomis Sayles & Co. L P Trims Stock Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat
People and Purpose: AbbVie's GC on Leading With Impact and Inspiring Change - Law.com
AbbVie (NYSE:ABBV) Trading 0.5% HigherTime to Buy? - MarketBeat
Shum Financial Group Inc. Buys Shares of 5,510 AbbVie Inc. (NYSE:ABBV) - MarketBeat
Principal Street Partners LLC Has $7.93 Million Stake in AbbVie Inc. (NYSE:ABBV) - MarketBeat
AbbVie Inc. (NYSE:ABBV) Shares Purchased by Fmr LLC - MarketBeat
AbbVie Inc. (NYSE:ABBV) Shares Sold by D.A. Davidson & CO. - MarketBeat
Dai ichi Life Insurance Company Ltd Decreases Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat
The Manufacturers Life Insurance Company Sells 29,310 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
Navigating Market Uncertainty: Intrinsic Value of AbbVie Inc - GuruFocus.com
Is AbbVie Inc. (ABBV) the Best Dividend Aristocrat Stock To Buy Right Now? - Insider Monkey
AbbVie (NYSE:ABBV) Trading Up 1.4%Time to Buy? - MarketBeat
Despite Neuroscience Setback, AbbVie Has Strong Recovery Ahead (ABBV) - Seeking Alpha
AbbVie Inc. stock rises Monday, still underperforms market - MarketWatch
AbbVie Stock Rises After Leerink Partners Upgrades Its Rating - Barchart
AbbVie Inc. (NYSE:ABBV) Shares Acquired by Associated Banc Corp - MarketBeat
AbbVie to Present at Citi's 2024 Global Healthcare Conference - StockTitan
AbbVie Inc. (NYSE:ABBV) Shares Bought by Harvest Fund Management Co. Ltd - MarketBeat
Proton Pump Inhibitors Market to Surpass Valuation of USD 7.35 Billion by 2031 | SkyQuest Technology - GlobeNewswire Inc.
FY2026 EPS Estimates for AbbVie Lifted by Leerink Partnrs - MarketBeat
FY2024 Earnings Forecast for AbbVie Issued By Zacks Research - MarketBeat
Daiwa Securities Group Inc. Buys 21,329 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
Summit Trail Advisors LLC Purchases 3,865 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
Westfield Capital Management Co. LP Has $125.15 Million Stake in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Alpha DNA Investment Management LLC Decreases Stock Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Connor Clark & Lunn Investment Management Ltd. Buys 2,838 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
AbbVie (NYSE:ABBV) Shares Acquired Rep. Marjorie Taylor Greene - MarketBeat
Are Hedge Funds Betting Big On AbbVie Inc. (ABBV)? - Insider Monkey
AbbVie Inc. (NYSE:ABBV) Shares Bought by Cerity Partners LLC - MarketBeat
AbbVie (NYSE:ABBV) Stock Rating Upgraded by Leerink Partnrs - MarketBeat
AbbVie upgraded to Outperform from Market Perform at Leerink - Yahoo Finance
Leerink Partners Upgrades AbbVie (ABBV) - MSN
Leerink Partners upgrades AbbVie shares to "Outperform" - TradingPedia
AbbVie Inc. (NYSE:ABBV) Receives $203.50 Consensus Target Price from Analysts - MarketBeat
AbbVie Inc. stock outperforms competitors on strong trading day - MarketWatch
AbbVie gains on Leerink Partners upgrade to Outperform - Yahoo Finance
AbbVie Jumps 5% On An Upgrade Despite Bristol Myers-Tied Setback - Yahoo! Voices
AbbVie: Upgrading to 'Strong Buy' After Pullback (NYSE:ABBV) - Seeking Alpha
AbbVie (NYSE:ABBV) Trading Up 2.9%Here's Why - MarketBeat
AbbVie Jumps Nearly 4% On An Upgrade Despite Bristol Myers-Tied Setback - MSN
One Veteran's Journey with Depression and AbbVie's Commitment to Mental Health Research - AbbVie
AbbVie, Nvidia Lead Friday's Market Cap Stock Movers - Investing.com
AbbVie, Nvidia Lead Friday's Market Cap Stock Movers By Investing.com - Investing.com Australia
AbbVie Inc. (NYSE:ABBV) Shares Purchased by Nwam LLC - MarketBeat
Zacks Research Weighs in on AbbVie's Q1 Earnings (NYSE:ABBV) - MarketBeat
Raymond James Trust N.A. Lowers Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat
49 Wealth Management LLC Increases Stock Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat
AbbVie (NYSE:ABBV) Upgraded by Leerink Partners to Outperform Rating - MarketBeat
AbbVie Inc. (NYSE:ABBV) Shares Sold by Edgewood Management LLC - MarketBeat
AbbVie Inc. (NYSE:ABBV) Position Trimmed by Eagle Asset Management Inc. - MarketBeat
Pacer Advisors Inc. Purchases 19,025 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
Segall Bryant & Hamill LLC Invests $8.17 Million in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Healthcare Stocks Got Crushed After the Election—Is It Time to Buy? - Morningstar
Fibrotic Diseases Treatment Market Top PlayersAbbVie Inc., - openPR
AbbVie (NYSE:ABBV) Trading 1.1% HigherStill a Buy? - MarketBeat
HealthInvest Partners AB Acquires 8,868 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
Banco Santander S.A. Has $12.75 Million Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Charles Schwab Investment Management Inc. Sells 1,137,780 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
AbbVie Inc. (NYSE:ABBV) is Integrated Investment Consultants LLC's 10th Largest Position - MarketBeat
Massachusetts Financial Services Co. MA Acquires 373,802 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
Mizuho Securities USA LLC Cuts Stock Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Bristol Myers Squibb’s stock soars after rival AbbVie reports disappointing schizophrenia-drug trial - MSN
LPL Financial LLC Acquires 92,492 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
0.57%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):